Back
Cabaletta Bio Vs. Bristol-Myers Squibb Industry Stock Comparison
Sell
32
CABA
Cabaletta Bio
Last Price:
4.00
Seasonality Move:
151.14%
Sell
43
BMY
Bristol-Myers Squibb
Last Price:
55.46
Seasonality Move:
3.45%
Sell
32
Cabaletta Bio (CABA)
is a Sell
Is Cabaletta Bio a Buy, Sell or Hold?
- The current Cabaletta Bio [CABA] share price is $3.71. The Score for CABA is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
- CABA is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
43
Bristol-Myers Squibb (BMY)
is a Sell
Is Bristol-Myers Squibb a Buy, Sell or Hold?
- The current Bristol-Myers Squibb [BMY] share price is $54.32. The Score for BMY is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
- BMY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CABA Stock Price Chart
What is Cabaletta Bio's stock price today?
-
The Cabaletta Bio share price today is $3.71
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CABA is experiencing slight buying pressure.
BMY Stock Price Chart
What is Bristol-Myers Squibb's stock price today?
-
The Bristol-Myers Squibb share price today is $54.32
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BMY is experiencing selling pressure, which indicates risk of future bearish movement.
CABA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.2 | Sell |
| Relative Strength Index (14 RSI): | 40.38 | Sell |
| Chaikin Money Flow: | 463288 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.89 - 4.55) | Sell |
| Bollinger Bands (100): | (3.92 - 7.78) | Sell |
BMY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.75 | Buy |
| Relative Strength Index (14 RSI): | 59.47 | Buy |
| Chaikin Money Flow: | -9902348 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (51.99 - 53.89) | Buy |
| Bollinger Bands (100): | (43.2 - 52.12) | Buy |
CABA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.89 | Sell |
| 20-day SMA: | 4.15 | Sell |
| 50-day SMA: | 4.49 | Sell |
| 200-day SMA: | 11.52 | Sell |
| 8-day EMA: | 3.9 | Sell |
| 20-day EMA: | 4.11 | Sell |
| 50-day EMA: | 4.69 | Sell |
| 200-day EMA: | 9.11 | Sell |
BMY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 53.22 | Buy |
| 20-day SMA: | 53 | Buy |
| 50-day SMA: | 51.11 | Buy |
| 200-day SMA: | 47.93 | Buy |
| 8-day EMA: | 53.54 | Buy |
| 20-day EMA: | 52.85 | Buy |
| 50-day EMA: | 51.19 | Buy |
| 200-day EMA: | 49.77 | Buy |
Cabaletta Bio Earnings Growth & CABA Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.62 per share, and a decrease next year of $0.14 per share.
Bristol-Myers Squibb Earnings Growth & BMY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.24 per share, a decrease next quarter of $0.00 per share, a decrease this year of $6.54 per share, and an increase next year of $6.19 per share.
Cabaletta Bio Technical Analysis
| Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Bristol-Myers Squibb Technical Analysis
| Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | ||||||||||
| 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||